Virax Biolabs Group Ltd - Ordinary Shares - Class A
VRAX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$437.35K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $437,349.00 |
|---|---|
| Enterprise Value | $-5,587,173.00 |
| Earnings per Share | $-12.64 |
| Beta | 1.39 |
| Outstanding Shares | 397,590 |
Return
| Return on Equity | -146.29% |
|---|---|
| Return on Assets | -133.16% |
| Return on Invested Capital | -164.44% |
Valuation & Multiples
| P/E Ratio | -0.05 |
|---|---|
| PEG | 0.26 |
| Price to Sales | - |
| Price to Book Ratio | 0.06 |
| Enterprise Value to Revenue | -234.46 |
| Enterprise Value to EBIT | 0.35 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.09 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 1, 2026
EPS Estimate
$-1.75
Consensus analyst estimateRevenue Estimate
$13,893
Consensus analyst estimateNext Earnings Call
Expected Date
December 2, 2026
EPS Estimate
$-1.75
Consensus analyst estimateRevenue Estimate
$13,893
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▲ 0.00% |
|---|---|
| Total Invested | $7 |
| Investors Holding | 1▲ 1.00% |